Abstract
The objective of this study is to investigate whether kisspeptin levels in early pregnancy have a better diagnostic value on early pregnancy outcome as compared with human chorionic gonadotropin (hCG). This study was a systematic review and meta-analysis aiming to investigate the diagnostic value of kisspeptin levels on early pregnancy outcome. The primary outcome was miscarriage or viable intrauterine pregnancy. Five studies were included for systematic review, and three studies were included for meta-analysis. Meta-analysis showed kisspeptin levels had a good diagnostic value with the area under the curve (AUC) 0.902 (0.866, 0.937) when kisspeptin was measured after 6 weeks of gestation. Sensitivity analysis demonstrated kisspeptin levels had a diagnostic value with AUC = 0.881 (0.855, 0.906). hCG levels had a diagnostic value with AUC = 0.834 (0.785, 0.883), which was inferior to the diagnostic value of kisspeptin (mean difference = 0.09 (0.02, 0.16)). Kisspeptin measurement has a potential for comparable or even higher accuracy than hCG in differentiating between miscarriage and viable intrauterine pregnancy after 6 weeks of gestation.
Similar content being viewed by others
Availability of Data and Materials
All data generated or analysed during this study are included in this published article.
Abbreviations
- AUC:
-
Area under the curve
- hCG:
-
Human chorionic gonadotropin
- CIs:
-
Confidence intervals
- SE:
-
Standard error
- sROC:
-
Summary receiver operating characteristic
- RIA:
-
Radioimmunoassay
- ELISA:
-
Enzyme-linked immunosorbent assay
References
Savitz DA, Hertz-Picciotto I, Poole C, Olshan AF. Epidemiologic measures of the course and outcome of pregnancy. Epidemiol Rev. 2002;24(2):91–101.
National Collaborating Centre for Ws, Children's H. National Institute for Health and Clinical Excellence: Guidance. Ectopic pregnancy and miscarriage: diagnosis and initial management in early pregnancy of ectopic pregnancy and miscarriage. London: Rcog National Collaborating Centre for Women's and Children's Health; 2012.
Jurkovic D, Overton C, Bender-Atik R. Diagnosis and management of first trimester miscarriage. Bmj. 2013;346:f3676.
Larsen EC, Christiansen OB, Kolte AM, Macklon N. New insights into mechanisms behind miscarriage. BMC Med. 2013;11:154.
Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319(4):189–94.
Farren J, Mitchell-Jones N, Verbakel JY, Timmerman D, Jalmbrant M, Bourne T. The psychological impact of early pregnancy loss. Hum Reprod Update. 2018;24(6):731–49.
Lok IH, Neugebauer R. Psychological morbidity following miscarriage. Best Pract Res Clin Obstet Gynaecol. 2007;21(2):229–47.
Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD, Fisher J, et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet (London, England). 2021;397(10285):1658–67.
Wieringa-de Waard M, Bonsel GJ, Ankum WM, Vos J, Bindels PJ. Threatened miscarriage in general practice: diagnostic value of history taking and physical examination. Br J Gen Pract. 2002;52(483):825–9.
Preisler J, Kopeika J, Ismail L, Vathanan V, Farren J, Abdallah Y, et al. Defining safe criteria to diagnose miscarriage: prospective observational multicentre study. Bmj. 2015;351:h4579.
West A, Vojta PJ, Welch DR, Weissman BE. Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1). Genomics. 1998;54(1):145–8.
Hu KL, Chang HM, Zhao HC, Yu Y, Li R, Qiao J. Potential roles for the kisspeptin/kisspeptin receptor system in implantation and placentation. Hum Reprod Update. 2019;25(3):326–43.
Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 1996;88(23):1731–7.
Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev. 2012;92(3):1235–316.
Skorupskaite K, George JT, Anderson RA. The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update. 2014;20(4):485–500.
Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 2001;411(6837):613–7.
Lee DK, Nguyen T, O'Neill GP, Cheng R, Liu Y, Howard AD, et al. Discovery of a receptor related to the galanin receptors. FEBS Lett. 1999;446(1):103–7.
Kotani M, Detheux M, Vandenbbogaerde A, Communi D, Vanderwinden JM, Le Poul E, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001;276(37):34631–6.
Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem. 2001;276(31):28969–75.
Hu KL, Zhao H, Yu Y, Li R. Kisspeptin as a potential biomarker throughout pregnancy. Eur J Obstet Gynecol Reprod Biol. 2019;240:261–6.
Abbara A, Al-Memar M, Phylactou M, Kyriacou C, Eng PC, Nadir R et al (2021) Performance of plasma kisspeptin as a biomarker for miscarriage improves with gestational age during the first trimester. Fertil Steril
Sullivan-Pyke C, Haisenleder DJ, Senapati S, Nicolais O, Eisenberg E, Sammel MD, et al. Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy. Fertil Steril. 2018;109(1):137–41.e2.
Jayasena CN, Abbara A, Izzi-Engbeaya C, Comninos AN, Harvey RA, Gonzalez Maffe J, et al. Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage. J Clin Endocrinol Metab. 2014;99(12):E2652–60.
Hu KL, Zhang Y, Yang Z, Zhao H, Xu H, Yu Y, et al. Predictive value of serum kisspeptin concentration at 14 and 21 days after frozen-thawed embryo transfer. Reprod BioMed Online. 2019;39(1):161–7.
Yu H, Liu J, Guo H, Chen C, Han Y, Cui Y. Prognostic value of repeated serum kisspeptin measurements in early first trimester pregnancy: a preliminary study. Reprod BioMed Online. 2019;38(3):465–71.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36.
de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003;100(19):10972–6.
Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349(17):1614–27.
Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab. 2003;88(2):914–9.
Okamoto SH, Healy DL, Morrow LM, Rogers PA, Trounson AO, Wood EC. Predictive value of plasma human chorionic gonadotrophin beta subunit in diagnosing ectopic pregnancy after in vitro fertilisation and embryo transfer. Br Med J (Clin Res Ed). 1987;294(6573):667–70.
Yamashita T, Okamoto S, Thomas A, MacLachlan V, Healy DL. Predicting pregnancy outcome after in vitro fertilization and embryo transfer using estradiol, progesterone, and human chorionic gonadotropin beta-subunit. Fertil Steril. 1989;51(2):304–9.
Porat S, Savchev S, Bdolah Y, Hurwitz A, Haimov-Kochman R. Early serum beta-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term pregnancy outcome. Fertil Steril. 2007;88(1):82–9.
Poikkeus P, Hiilesmaa V, Tiitinen A. Serum HCG 12 days after embryo transfer in predicting pregnancy outcome. Hum Reprod (Oxford, England). 2002;17(7):1901–5.
Chi H, Qiao J, Li H, Liu P, Ma C. Double measurements of serum HCG concentration and its ratio may predict IVF outcome. Reprod BioMed Online. 2010;20(4):504–9.
Savaris RF. Kisspeptin as a biomarker for miscarriage: let’s wait! Fertil Steril. 2018;109(1):67.
Gude NM, Roberts CT, Kalionis B, King RG. Growth and function of the normal human placenta. Thromb Res. 2004;114(5-6):397–407.
Ramachandran R, Patterson M, Murphy KG, Dhillo WS, Patel S, Kazarian A, et al. Preanalytical factors affecting RIA measurement of plasma kisspeptin. Clin Chem. 2008;54(3):615–7.
Li R, Hu KL. Kisspeptin, a promising biomarker for miscarriage in early pregnancy. Fertil Steril. 2021;116(3):672–3.
Funding
This study was supported by grants from National Natural Science Foundation of China (81873835 and 82071726).
Author information
Authors and Affiliations
Contributions
KL.H conceived the idea; KL.H and Z.C reviewed the literature and extracted the data; KL.H, X.L and W.D assessed the quality of included studies; KL.H designed the study and wrote the manuscript and designed the figures and tables; H.Z and L.M and H.Y revised the manuscript. All authors participated in the discussion of the analysis and interpretation of data in this article.
Corresponding authors
Ethics declarations
Ethics Approval and Consent to Participate
Not applicable.
Consent for Publication
All authors approved the final version of the manuscript and consent for publication.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Supplementary Fig. 1
(PNG 28 kb)
Supplementary Fig. 2
(PNG 24 kb)
Supplementary Fig. 3
(PNG 25 kb)
Supplementary Table 1
(DOCX 15 kb)
Rights and permissions
About this article
Cite this article
Hu, KL., Chen, Z., Deng, W. et al. Diagnostic Value of Kisspeptin Levels on Early Pregnancy Outcome: a Systematic Review and Meta-analysis. Reprod. Sci. 29, 3365–3372 (2022). https://doi.org/10.1007/s43032-022-00856-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-022-00856-8